Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Swine erysipelas therapeutic drug

A technology for the treatment of porcine erysipelas, which is applied in antibacterial drugs, pharmaceutical formulas, plant raw materials, etc., and can solve problems such as slow onset of action and poor curative effect

Inactive Publication Date: 2017-05-31
鼎正生物药业(天津)有限公司
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The present invention aims at the technical defects of the prior art, and provides a medicine for treating porcine erysipelas, so as to solve the technical problems of poor curative effect and slow onset of medicine for treating porcine erysipelas in the prior art

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0015] A medicine for treating swine erysipelas, which is composed of the following ingredients in parts by weight: 9 parts of unicorn, 6 parts of rhododendron, 6 parts of farrohai, 3 parts of white flower tea, 1 part of centipede, 1 part of genus genus, and kelp 0.5 parts, 0.5 parts of borneol, 2 parts of ancient sheep vine, 2 parts of chicken bone fragrance, and 1 part of auspicious grass. Its dosage form is powder.

Embodiment 2

[0017] A medicine for treating swine erysipelas, which is composed of the following ingredients in parts by weight: 9 parts of unicorn, 6 parts of rhododendron, 6 parts of farrohai, 3 parts of white flower tea, 1 part of centipede, 1 part of genus genus, and kelp 0.5 parts, 0.5 parts of borneol, 2 parts of ancient sheep vine, 1 part of auspicious grass. Its dosage form is a pill.

Embodiment 3

[0019] A medicine for treating swine erysipelas, which is composed of the following ingredients in parts by weight: 9 parts of unicorn, 6 parts of rhododendron, 6 parts of farrohai, 3 parts of white flower tea, 1 part of centipede, 1 part of genus genus, and kelp 0.5 parts, 0.5 parts of borneol, 2 parts of chicken bone incense, and 1 part of auspicious grass. Its dosage form is a pill.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a swine erysipelas therapeutic drug. The drug comprises the following components by weight: 9 parts of Striga asiatica, 6 parts of azalea, 6 parts of Heracleum apaense, 3 parts of Jasminum amplexicaule Buch, 1 part of Lycopodium annotinum, 1 part of roughhaired holly root, 0.5 part of Gelsmium elegans, and 0.5 part of borneol. On the basis, 2 parts by weight of root of Streptoculon griffithii Hook, 2 parts by weight of root of Croton crassifolius Geisel or 1 part by weight of Pink Reineckea Herb can be further added. Through reasonable design of the traditional Chinese medicinal components, the drug formula is obtained, and the drug has prominent curative effect on swine erysipelas, fast effect, and has effective rate and cure rate both superior to those of the prior art.

Description

technical field [0001] The invention relates to the technical field of veterinary drugs, in particular to a drug for treating porcine erysipelas. Background technique [0002] Erysipelothrix rhusiopathiae is an acute febrile infectious disease caused by Erysipelothrix rhusiopathiae, commonly known as Erysipelothrix bacillus. Its main features are high fever, acute sepsis, skin rash (subacute), chronic verrucous endocarditis And skin necrosis and multiple non-suppurative arthritis (chronic). At present, intensive pig farms are relatively rare, but they have not been completely controlled. The disease is distributed worldwide. [0003] In the prior art, the treatment for porcine erysipelas is mainly based on antibiotics. However, from a practical point of view, if antibiotics are applied on a large scale, it will easily lead to microbial resistance, and at the same time, it will easily affect the food safety of the pig meat. Contents of the invention [0004] The inventio...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/82A61K36/63A61P31/04A61K31/045
Inventor 刘鼎阔王立红张凤洪张俊霞
Owner 鼎正生物药业(天津)有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com